Runben Biotechnology Co., Ltd. (SHA:603193)
34.87
+1.85 (5.60%)
Apr 24, 2025, 2:45 PM CST
111.08% (1Y)
Market Cap | 13.36B |
Revenue (ttm) | 1.25B |
Net Income (ttm) | 306.18M |
Shares Out | 404.59M |
EPS (ttm) | 0.76 |
PE Ratio | 43.48 |
Forward PE | 42.58 |
Dividend | 0.18 (0.53%) |
Ex-Dividend Date | Oct 30, 2024 |
Volume | 5,927,246 |
Average Volume | 3,389,362 |
Open | 32.80 |
Previous Close | 33.02 |
Day's Range | 32.80 - 35.50 |
52-Week Range | 15.80 - 37.99 |
Beta | n/a |
RSI | 49.05 |
Earnings Date | Apr 25, 2025 |